Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Pharmacokinetic Study of Granexin® Gel in Patients With Diabetic Foot Ulcers

NCT02652754 is registered in ClinicalTrials.gov with Xequel Bio, Inc. as lead sponsor.

NCT NCT02652754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02652754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Pharmacokinetic Study of Granexin® Gel in Patients With Diabetic Foot Ulcers
Lead sponsor
Xequel Bio, Inc.
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2015
Completion date
May 31, 2018
Enrollment
16 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcers